Orchestra BioMed Holdings Inc (NASDAQ: OBIO) started the day on Thursday, with a price decrease of -5.43% at $4.18, before settling in for the price of $4.42 at the close. Taking a more long-term approach, OBIO posted a 52-week range of $2.20-$6.50.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -273.68%. Meanwhile, its Annual Earning per share during the time was -273.68%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.65%. This publicly-traded company’s shares outstanding now amounts to $56.46 million, simultaneously with a float of $45.93 million. The organization now has a market capitalization sitting at $236.02 million. At the time of writing, stock’s 50-day Moving Average stood at $3.19, while the 200-day Moving Average is $3.36.
Orchestra BioMed Holdings Inc (OBIO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Orchestra BioMed Holdings Inc’s current insider ownership accounts for 22.05%, in contrast to 34.41% institutional ownership. According to the most recent insider trade that took place on Sep 19 ’25, this organization’s Director bought 1,000 shares at the rate of 2.45, making the entire transaction reach 2,450 in total value, affecting insider ownership by 108,482. Preceding that transaction, on Aug 25 ’25, Company’s Director bought 5,760 for 2.61, making the whole transaction’s value amount to 15,034. This particular insider is now the holder of 71,709 in total.
Orchestra BioMed Holdings Inc (OBIO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year. Orchestra BioMed Holdings Inc’s EPS decrease for this current 12-month fiscal period is -5.65% and is forecasted to reach -1.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.29% through the next 5 years, which can be compared against the -273.68% growth it accomplished over the previous five years trading on the market.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Orchestra BioMed Holdings Inc (OBIO). It’s Quick Ratio in the last reported quarter now stands at 4.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 83.69.
In the same vein, OBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.82, a figure that is expected to reach -0.38 in the next quarter, and analysts are predicting that it will be -1.57 at the market close of one year from today.
Technical Analysis of Orchestra BioMed Holdings Inc (OBIO)
If we take a close look at the recent performances of Orchestra BioMed Holdings Inc (NASDAQ: OBIO), its last 5-days Average volume was 0.41 million that shows progress from its year to date volume of 0.3 million. During the previous 9 days, stock’s Stochastic %D was recorded 85.41% While, its Average True Range was 60.67.
Raw Stochastic average of Orchestra BioMed Holdings Inc (OBIO) in the period of the previous 100 days is set at 86.46%, which indicates a major rise in contrast to 69.61% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.31 that was higher than 0.21 volatility it exhibited in the past 100-days period.
